Article
Drug-loaded Microbubble Delivery System to Enhance PD-L1 Blockade Immunotherapy with Remodeling Immune Microenvironment
2022-10-28
Abstract excerpt
<title>Abstract</title> <p>Background Compared with the conventional tumor therapeutic modalities, immune checkpoint blockade (<italic>e.g.</italic>, PD-1/PD-L1) immunotherapy demonstrates great promise in the treatment of metastatic cancers. Although PD-L1 blockade immunotherapy is applied to a variety of tumor types, only a small number of patients respond to this treatment. The efficacy of PD-L1 blockade immu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7a2d0185-e9a0-5e7d-bef8-298113ecc06f
- DOI
- 10.21203/rs.3.rs-2149010/v1
